Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700013205

Trial Profile

Clinical Trials Insight: 700013205

Phase of Trial: Phase I

Latest Information Update: 14 Jun 2007

At a glance

  • Drugs XTL 2125 (Primary)
  • Indications Hepatitis C
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors XTL Biopharmaceuticals
  • Most Recent Events

    • 14 Jun 2007 Status change
    • 06 Jun 2007 Results have been reported.
    • 08 Jun 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top